Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins.
about
Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin12(S)-Hydroxyheptadeca-5Z,8E,10E-trienoic acid suppresses UV-induced IL-6 synthesis in keratinocytes, exerting an anti-inflammatory activity12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclinIncreased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasisRegulated formation of eicosanoidsArachidonic acid metabolism by human monocytes. Studies with platelet-depleted culturesArachidonic acid metabolism and modulation of in vitro anaphylaxis by 5,8,11,14-eicosatetraynoic acid and 9a,12a-octadecadiynoic acidRedox-dependent anti-inflammatory signaling actions of unsaturated fatty acidsThromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxidesPGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP212-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptorSynthesis, characterization and applications of a perdeuterated amphipol.Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma.Thromboxane synthesis and the platelet release reaction in Bernard-Soulier syndrome, thrombasthenia Glanzmann and Hermansky-Pudlak syndrome.The discovery of the leukotrienes.Role of platelets in hemostasis and thrombosis.Thromboxane A synthase-independent production of 12-hydroxyheptadecatrienoic acid, a BLT2 ligand.Effect of the prostaglandin precursor, arachidonic acid, on histamine stimulated gastric secretion in the conscious dog, and observations on the effect of inhibiting endogenous prostaglandin synthesisThe mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency.Mechanism and modification of bradykinin-induced coronary vasodilationRole of magnesium in Escherichia coli alkaline phosphataseAcetylation of prostaglandin synthase by aspirinSynthesis and biological properties of a 9,11-azo-prostanoid: highly active biochemical mimic of prostaglandin endoperoxidesAssessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia.Leukocyte-platelet interaction. Release of hydrogen peroxide by granulocytes as a modulator of platelet reactionsThe expression of COX-2 in VEGF-treated endothelial cells is mediated through protein tyrosine kinaseIndividual variations of prostanoid agonist responses in rabbit aorta: evidence for the independent regulation of prostanoid receptor subtypesEleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids.The prostanoids in hemostasis and thrombosis: a review.Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.Neutrophil aggregation and degranulation. Effect of arachidonic acid.Prostaglandin synthesis inhibitors: effect on angiotensin II- and oxytocin-induced contractions in rat uterine smooth muscleProstaglandins E1 and E2 interact with prostaglandin F2alpha to regulate initiation of DNA replication and cell division in swiss 3T3 cells.Arachidonate metabolism via lipoxygenase and 12L-hydroperoxy-5,8,10,14-icosatetraenoic acid peroxidase sensitive to anti-inflammatory drugs.Prostaglandin E2 receptor distribution and function in the gastrointestinal tract.Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion.An integrated model of eicosanoid metabolism and signaling based on lipidomics flux analysis.Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway.
P2860
Q28166708-007088CB-56AA-41A3-9FCA-76822AE49865Q28261286-B7535D8C-0DDF-44BB-A6BC-896906A123B3Q28274624-AAEC2102-6C2A-4EE2-AB14-A803AD194C84Q28277612-03E7323C-6862-4FCB-AA82-AD75E470DC23Q28336176-8581C026-6EC4-45C6-8D5F-7DDBC90F85DBQ28366333-99BB4C77-7FD0-449B-A2B1-E5EE7C1ADF03Q28366578-5F9F1C78-86A3-45AB-BAB0-E736456C4098Q28367247-3CF0099F-5952-47D0-8340-D723DA70E0A2Q28386488-3C3C5954-29CF-4E1F-86A6-B15D858CEAD7Q28619497-8244638A-94A3-44C6-BFC1-5F38AFB89478Q28731227-75D3BD3E-2B70-4F4E-BED8-FEDA1BB3A48BQ30579732-D8617B1B-76DF-4045-ABF7-CE5B124805E2Q30782383-2C57DBD9-E3FB-4062-BDB0-1757F461DA5DQ33458561-00A59AEB-44CD-4362-B26B-D1F07BF2D049Q33471694-3F541986-211E-4650-8D7E-ECC24A772383Q33836669-9257FBF9-17D1-4C58-90BC-F7BC94341C64Q34050195-DA4451C6-AC6E-49C1-A692-C0CBBEF43DACQ34368967-62CF73D4-824E-4342-9B88-485E1953FB14Q34472994-059DE08B-6502-4C10-A18F-821950CBAB0CQ34481430-FC1909EB-B136-4B29-88C8-EEA4348DF662Q35076168-7316671E-0EE3-446B-9F10-28CF1FD36766Q35080604-85AC1CE8-5FC2-45BA-927E-E800FE333686Q35085069-78E0D2F6-6B7A-4CDC-8931-DB0C77A22A7FQ35085661-A2720B79-C432-47F4-A27A-62970CA142F7Q35087532-F04DB5EA-6033-4CB2-BE7B-7C3B27FB8AB7Q35129581-8E6F6B21-3683-42AC-B103-90E8BEB4A0DDQ35199795-135BC0EC-CC72-418C-BB0C-40CD58897FD5Q35609405-EC3FB587-A319-4847-B0E8-58A594205A23Q35754932-90E7B560-5139-4B9E-B660-55C6E347015EQ35755755-E3BFB803-F660-4D17-95E6-4D06D6EE3391Q35863726-F84B0E1B-B6B7-4BCF-9273-233E693EC837Q35905552-C40A69EA-EBC4-4602-AC28-3C52351F6130Q36092978-DE9C315D-F254-4DFC-92F6-22B6FEDA398BQ36097753-652F6A4D-E3BF-484E-95C0-ACA916A5179FQ36308198-7B0AF357-8D35-41D6-ADB7-6BA21271800DQ36351736-46B0DA2B-493D-4E77-9875-10D99DA20E06Q36611067-7B6103B0-25C1-4B4B-A939-CE015F17B686Q36738131-141F6476-AD7E-4E80-8328-A56CF22C4859Q37263745-8892227C-16A4-403B-9BF5-E4B8434B428DQ37339316-556EDC88-38E9-46B8-8C27-67338EB9BB5E
P2860
Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins.
description
1974 nî lūn-bûn
@nan
1974 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1974 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1974年の論文
@ja
1974年論文
@yue
1974年論文
@zh-hant
1974年論文
@zh-hk
1974年論文
@zh-mo
1974年論文
@zh-tw
1974年论文
@wuu
name
Prostaglandin endoperoxides. A ...... and release of prostaglandins.
@ast
Prostaglandin endoperoxides. A ...... and release of prostaglandins.
@en
type
label
Prostaglandin endoperoxides. A ...... and release of prostaglandins.
@ast
Prostaglandin endoperoxides. A ...... and release of prostaglandins.
@en
prefLabel
Prostaglandin endoperoxides. A ...... and release of prostaglandins.
@ast
Prostaglandin endoperoxides. A ...... and release of prostaglandins.
@en
P2860
P356
P1476
Prostaglandin endoperoxides. A ...... and release of prostaglandins.
@en
P2093
P2860
P304
P356
10.1073/PNAS.71.10.3824
P407
P577
1974-10-01T00:00:00Z